Skip to content

Axonics 2201Recalls & reported problems

Axonics Modulation Technologies, Inc. · Tined Lead · Class 3 · Implant

Adverse event reports
6
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 10810005340158), received between Feb 28, 2020 and Mar 12, 2024 — classified as 1 injury, 5 malfunctions.

The most frequently reported specific device problem is “Migration” (4 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 1 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Migration4
  • Failure to Read Input Signal1
  • Impedance Problem1
  • Material Erosion1

Patient problems

  • Failure of Implant3
  • Erosion1
  • No Known Impact Or Consequence To Patient1
  • Pain1
  • Therapeutic Response, Decreased1

Recent adverse event reports

The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.

  • InjuryMar 12, 2024Migration; Migration

    THE PATIENT UNDERWENT REVISION SURGERY DUE TO LEAD MIGRATION.

    Patient problems: Failure of Implant

    MAUDE report 18887139 ↗
  • MalfunctionJun 18, 2020Migration; Migration

    PATIENT HAD A MASSAGE DONE. THE MASSAGE SESSION INCLUDED THE AREA OF THE IPG (NEUROSTIMULATOR) AND TINED LEAD INSERTION SITE. PATIENT WAS NOT RECEIVING EFFECTIVE THERAPY. X-RAYS WERE PERFORMED AND RESULTS SHOW THE LEAD HAD MIGRATED INWARD. THE PATIENT DECIDED TO HAVE THE SYSTEM EXPLANTED DUE TO RECOVERY TIME FOR A LEAD REVISION SURGERY.

    Patient problems: Therapeutic Response, Decreased

    MAUDE report 10171467 ↗
  • MalfunctionJun 11, 2020Migration; Migration

    PATIENT'S LEAD MOVED AFTER THEIR FINAL IMPLANT. REVISION SURGERY NEEDED TO REPLACE THE LEAD.

    Patient problems: Failure of Implant

    MAUDE report 10146497 ↗
  • MalfunctionMay 8, 2020Material Erosion; Material Erosion

    PATIENT UNDERWENT A RAPID WEIGHT LOSS PROGRAM WHERE THEY HAD LOST 38 POUNDS IN 2 MONTHS. THE DOCTOR STATED THE LEAD STRESS COIL AT THE IPG (NEUROSTIMULATOR) SITE HAD ERODED THROUGH THE SKIN. THE PATIENT WAS SCHEDULED FOR A FULL SYSTEM EXPLANT ON (B)(6) 2020.

    Patient problems: Erosion

    MAUDE report 10039444 ↗
  • MalfunctionApr 8, 2020Failure to Read Input Signal; Impedance Problem; Failure to Read Input Signal; Impedance Problem

    WHEN THE LEAD STIMULATION CABLE WAS ATTACHED TO THE TINED LEAD, THE IMPEDANCE OF ALL 4 CONTACTS CAME UP AS OPEN IN RED AND THE CABLE WAS UNABLE TO READ THE THRESHOLDS FOR EACH CONTACT. THE NEEDLE TEST STIMULATION CABLE WAS USED TO COMPLETE THE CASE.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 9941486 ↗
  • MalfunctionFeb 28, 2020Migration; Migration

    SEE SECTION H, NUMBER 6, EVENT PROBLEM AND EVALUATION CODES.

    Patient problems: Failure of Implant; Pain

    MAUDE report 9772183 ↗

Other Implanted Electrical Device Intended For Treatment Of Fecal Incontinence devices

All Implanted Electrical Device Intended For Treatment Of Fecal Incontinence devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.